Opus Genetics, Stock Price To Earnings To Growth
| IRD Stock | 1.13 0.02 1.74% |
Opus Genetics, fundamentals help investors to digest information that contributes to Opus Genetics,'s financial success or failures. It also enables traders to predict the movement of Opus Stock. The fundamental analysis module provides a way to measure Opus Genetics,'s intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Opus Genetics, stock.
Opus |
Opus Genetics, Company Price To Earnings To Growth Analysis
Opus Genetics,'s PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
| Competition |
Based on the latest financial disclosure, Opus Genetics, has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The price to earnings to growth for all United States stocks is 100.0% higher than that of the company.
Opus Price To Earnings To Growth Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Opus Genetics,'s direct or indirect competition against its Price To Earnings To Growth to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Opus Genetics, could also be used in its relative valuation, which is a method of valuing Opus Genetics, by comparing valuation metrics of similar companies.Opus Genetics, is currently under evaluation in price to earnings to growth category among its peers.
Opus Fundamentals
| Return On Equity | -0.64 | ||||
| Return On Asset | -0.39 | ||||
| Operating Margin | (2.07) % | ||||
| Current Valuation | (962.64 K) | ||||
| Shares Outstanding | 31.57 M | ||||
| Shares Owned By Insiders | 16.14 % | ||||
| Shares Owned By Institutions | 16.64 % | ||||
| Number Of Shares Shorted | 672.99 K | ||||
| Price To Book | 1.04 X | ||||
| Price To Sales | 4.26 X | ||||
| Revenue | 19.05 M | ||||
| Gross Profit | (15.39 M) | ||||
| EBITDA | (29.47 M) | ||||
| Net Income | (9.99 M) | ||||
| Total Debt | 4.04 M | ||||
| Book Value Per Share | 1.31 X | ||||
| Cash Flow From Operations | (1.11 M) | ||||
| Short Ratio | 3.44 X | ||||
| Earnings Per Share | (1.09) X | ||||
| Target Price | 10.5 | ||||
| Number Of Employees | 14 | ||||
| Beta | 0.24 | ||||
| Market Capitalization | 35.67 M | ||||
| Total Asset | 53.95 M | ||||
| Retained Earnings | (81.47 M) | ||||
| Working Capital | 49.91 M | ||||
| Net Asset | 53.95 M |
About Opus Genetics, Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Opus Genetics,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Opus Genetics, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Opus Genetics, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out Opus Genetics, Piotroski F Score and Opus Genetics, Altman Z Score analysis. For information on how to trade Opus Stock refer to our How to Trade Opus Stock guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Opus Genetics,. If investors know Opus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Opus Genetics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Opus Genetics, is measured differently than its book value, which is the value of Opus that is recorded on the company's balance sheet. Investors also form their own opinion of Opus Genetics,'s value that differs from its market value or its book value, called intrinsic value, which is Opus Genetics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Opus Genetics,'s market value can be influenced by many factors that don't directly affect Opus Genetics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Opus Genetics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Opus Genetics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Opus Genetics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.